In a study by Vazquez-Martin et al., it was discovered that metformin inhibits the growth of breast cancer cells by reducing the levels of HER2 through the modulation of the AMPK/mTOR/p70S6K1 axis [222]. Here, ERBB2 is linked to breast carcinoma.